NORWALK, Conn., July 28, 2022 (GLOBE NEWSWIRE) -- Reed's, Inc. (NASDAQ: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, all-natural ginger beve

Coca-Cola (KO) Q2 Earnings and Revenues Top Estimates

12:15pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
Coke (KO) delivered earnings and revenue surprises of 4.48% and 5.26%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
NORWALK, Conn., July 21, 2022 (GLOBE NEWSWIRE) -- Reed’s, Inc. (NASDAQ: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, all-natural ginger be

PepsiCo (PEP) Beats Q2 Earnings and Revenue Estimates

11:15am, Tuesday, 12'th Jul 2022 Zacks Investment Research
PepsiCo (PEP) delivered earnings and revenue surprises of 7.51% and 2.32%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Reed’s Appoints Thomas Kosler to Board of Directors

08:05pm, Thursday, 07'th Jul 2022 GlobeNewswire Inc.
NORWALK, Conn., July 07, 2022 (GLOBE NEWSWIRE) -- Reed’s, Inc. (NASDAQ: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, all-natural ginger be
Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade. Acutus Medical, Inc. (NASDAQ: AFIB) climbed 87.6% to cl
Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade. Acutus Medical, Inc. (NASDAQ: AFIB) gained 82.4% to $0.9819 after the company anno

Epizyme + 20 Stocks Moving In Monday's Pre-Market Session

10:31am, Monday, 27'th Jun 2022 Benzinga
Gainers Tenax Therapeutics, Inc. (NASDAQ: TENX) rose 90.1% to $0.59 in pre-market trading after dipping more than 46% on Friday. Epizyme, Inc. (NASDAQ: EPZM) rose 57.2% to $1.50 in pre-market tradi
NORWALK, Conn., June 14, 2022 (GLOBE NEWSWIRE) -- Reed’s, Inc. (NASDAQ: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, all-natural ginger be
NORWALK, Conn., June 14, 2022 (GLOBE NEWSWIRE) -- Reed's, Inc. (NASDAQ: REED) (“Reed's” or the “Company”), owner of the nation's leading portfolio of handcrafted, all-natural ginger beverages,
Reed's, Inc. (NASDAQ:REED ) Q1 2022 Earnings Conference Call May 16, 2022 5:00 PM ET Company Participants Norman Snyder – Chief Executive Officer Tom Spisak – Chief Financial Officer Conference Ca

Reeds (REED) Reports Q1 Loss, Lags Revenue Estimates

10:05pm, Monday, 16'th May 2022 Zacks Investment Research
Reeds (REED) delivered earnings and revenue surprises of -25% and 11.08%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Reeds (REED) delivered earnings and revenue surprises of -25% and 11.08%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Reeds (REED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Reeds (REED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE